Company Filing History:
Years Active: 2024
Title: John Dubczak: Innovator in Recombinant Amebocyte Lysate
Introduction
John Dubczak is a notable inventor based in Summerville, SC (US). He has made significant contributions to the field of biotechnology, particularly in the development of hybrid amebocyte lysate compositions. His work is crucial for detecting and quantifying endotoxin in various samples.
Latest Patents
John Dubczak holds a patent for "Recombinant amebocyte lysate and uses thereof." This invention relates to hybrid amebocyte lysate compositions, which include both native and recombinant components. The patent plays a vital role in enhancing the accuracy of endotoxin detection.
Career Highlights
John Dubczak is associated with Charles River Laboratories, Inc., a leading company in the life sciences sector. His expertise in biotechnology has contributed to the advancement of research and development in this field.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues such as Norman R. Wainwright and Masakazu Tsuchiya. These partnerships have fostered innovation and have been instrumental in the success of various projects.
Conclusion
John Dubczak's contributions to biotechnology, particularly through his patent on recombinant amebocyte lysate, highlight his role as an innovator in the field. His work continues to impact the detection of endotoxins, showcasing the importance of his inventions.